Minami, Hironobu <br/><br/>
Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors.  [electronic resource] 

 -  Cancer science  Jul 2008 
 - 1492-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1349-7006 
<br/><br/><label>Standard No.: </label>10.1111/j.1349-7006.2008.00837.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Benzenesulfonates--adverse effects<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Female<br/>Fluorodeoxyglucose F18<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Phosphorylation<br/>Positron-Emission Tomography<br/>Protein Kinase Inhibitors--therapeutic use<br/>Pyridines--adverse effects<br/>Sorafenib